TrimRX
US$ 25.29
should glp-1 agonists be open access receptor GLP-1 receptor agonists show promise
Description
2 The American Diabetes Association 2016 guideline details a number of second-line options for use following MET and does not give preference to one drug class over the other
Indian J Gastroenterol
A tablet form of the semaglutide-based drug Wegovy was given the go-ahead in January
Cardiovasc Diabetol 24 , 87 (2025)
The selection process is illustrated in the flow diagram ( Figure 1 )
